210 related articles for article (PubMed ID: 27155012)
1. Elucidation of tonic and activated B-cell receptor signaling in Burkitt's lymphoma provides insights into regulation of cell survival.
Corso J; Pan KT; Walter R; Doebele C; Mohr S; Bohnenberger H; Ströbel P; Lenz C; Slabicki M; Hüllein J; Comoglio F; Rieger MA; Zenz T; Wienands J; Engelke M; Serve H; Urlaub H; Oellerich T
Proc Natl Acad Sci U S A; 2016 May; 113(20):5688-93. PubMed ID: 27155012
[TBL] [Abstract][Full Text] [Related]
2. HSP90 promotes Burkitt lymphoma cell survival by maintaining tonic B-cell receptor signaling.
Walter R; Pan KT; Doebele C; Comoglio F; Tomska K; Bohnenberger H; Young RM; Jacobs L; Keller U; Bönig H; Engelke M; Rosenwald A; Urlaub H; Staudt LM; Serve H; Zenz T; Oellerich T
Blood; 2017 Feb; 129(5):598-608. PubMed ID: 28064214
[TBL] [Abstract][Full Text] [Related]
3. NF-ATc2 induces apoptosis in Burkitt's lymphoma cells through signaling via the B cell antigen receptor.
Kondo E; Harashima A; Takabatake T; Takahashi H; Matsuo Y; Yoshino T; Orita K; Akagi T
Eur J Immunol; 2003 Jan; 33(1):1-11. PubMed ID: 12594826
[TBL] [Abstract][Full Text] [Related]
4. SH2 domain-containing inositol 5-phosphatases support the survival of Burkitt lymphoma cells by promoting energy metabolism.
Mayr F; Kruse V; Fuhrmann DC; Wolf S; Löber J; Alsouri S; Paglilla N; Lee K; Chapuy B; Brüne B; Zenz T; Häupl B; Oellerich T; Engelke M
Haematologica; 2024 May; 109(5):1445-1459. PubMed ID: 37916396
[TBL] [Abstract][Full Text] [Related]
5. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
Schmitz R; Young RM; Ceribelli M; Jhavar S; Xiao W; Zhang M; Wright G; Shaffer AL; Hodson DJ; Buras E; Liu X; Powell J; Yang Y; Xu W; Zhao H; Kohlhammer H; Rosenwald A; Kluin P; Müller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Ogwang MD; Reynolds SJ; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pittaluga S; Wilson W; Waldmann TA; Rowe M; Mbulaiteye SM; Rickinson AB; Staudt LM
Nature; 2012 Oct; 490(7418):116-20. PubMed ID: 22885699
[TBL] [Abstract][Full Text] [Related]
6. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
Young RM; Wu T; Schmitz R; Dawood M; Xiao W; Phelan JD; Xu W; Menard L; Meffre E; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Staudt LM
Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13447-54. PubMed ID: 26483459
[TBL] [Abstract][Full Text] [Related]
7. Costimulatory signals distinctively affect CD20- and B-cell-antigen-receptor-mediated apoptosis in Burkitt's lymphoma/leukemia cells.
Mimori K; Kiyokawa N; Taguchi T; Suzuki T; Sekino T; Nakajima H; Saito M; Katagiri YU; Isoyama K; Yamada K; Matsuo Y; Fujimoto J
Leukemia; 2003 Jun; 17(6):1164-74. PubMed ID: 12764385
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction pathways in Burkitt's lymphoma cell lines BL41 and DG75 with different sensitivity to doxorubicin.
Shlapatska LM; Berdova GG; Kovalevska LM; Kulyk GI; Klein G; Sidorenko SP; Chekhun VF
Exp Oncol; 2004 Sep; 26(3):210-6. PubMed ID: 15494689
[TBL] [Abstract][Full Text] [Related]
9. Actinin-4 controls survival signaling in B cells by limiting the lateral mobility of B-cell antigen receptors.
Alsouri S; Ambrose A; Mougios N; Paglilla N; Mayr F; Choi K; Loeber J; Chapuy B; Haeupl B; Opazo F; Oellerich T; Gold M; Engelke M
Eur J Immunol; 2024 Mar; 54(3):e2350774. PubMed ID: 38299456
[TBL] [Abstract][Full Text] [Related]
10. Concomitant high expression of Toll-like receptor (TLR) and B-cell receptor (BCR) signalling molecules has clinical implications in mantle cell lymphoma.
Akhter A; Street L; Ghosh S; Burns BF; Elyamany G; Shabani-Rad MT; Stewart DA; Mansoor A
Hematol Oncol; 2017 Mar; 35(1):79-86. PubMed ID: 26354285
[TBL] [Abstract][Full Text] [Related]
11. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
[TBL] [Abstract][Full Text] [Related]
12. CD40-triggered protein tyrosine phosphorylation on Vav and on phosphatidylinositol 3-kinase correlates with survival of the Ramos-Burkitt lymphoma B cell line.
Padmore L; An S; Gunby RH; Kelly K; Radda GK; Knox KA
Cell Immunol; 1997 May; 177(2):119-28. PubMed ID: 9178638
[TBL] [Abstract][Full Text] [Related]
13. Regulation of tyrosine phosphorylation during the CD40-mediated rescue of Ramos-BL B cells from BCR-triggered apoptosis.
Hristov KK; Knox KA; Mitev VI
Int J Mol Med; 2005 Nov; 16(5):937-41. PubMed ID: 16211267
[TBL] [Abstract][Full Text] [Related]
14. Identification of Ezrin-Radixin-Moesin proteins as novel regulators of pathogenic B-cell receptor signaling and tumor growth in diffuse large B-cell lymphoma.
Pore D; Bodo J; Danda A; Yan D; Phillips JG; Lindner D; Hill BT; Smith MR; Hsi ED; Gupta N
Leukemia; 2015 Sep; 29(9):1857-67. PubMed ID: 25801911
[TBL] [Abstract][Full Text] [Related]
15. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
[TBL] [Abstract][Full Text] [Related]
16. The B-cell receptor controls fitness of MYC-driven lymphoma cells via GSK3β inhibition.
Varano G; Raffel S; Sormani M; Zanardi F; Lonardi S; Zasada C; Perucho L; Petrocelli V; Haake A; Lee AK; Bugatti M; Paul U; Van Anken E; Pasqualucci L; Rabadan R; Siebert R; Kempa S; Ponzoni M; Facchetti F; Rajewsky K; Casola S
Nature; 2017 Jun; 546(7657):302-306. PubMed ID: 28562582
[TBL] [Abstract][Full Text] [Related]
17. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells.
Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW
Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865
[TBL] [Abstract][Full Text] [Related]
18. MARCKS regulates tonic and chronic active B cell receptor signaling.
Xu C; Fang Y; Yang Z; Jing Y; Zhang Y; Liu C; Liu W
Leukemia; 2019 Mar; 33(3):710-729. PubMed ID: 30209404
[TBL] [Abstract][Full Text] [Related]
19. Processing of CD74 by the Intramembrane Protease SPPL2a Is Critical for B Cell Receptor Signaling in Transitional B Cells.
Hüttl S; Kläsener K; Schweizer M; Schneppenheim J; Oberg HH; Kabelitz D; Reth M; Saftig P; Schröder B
J Immunol; 2015 Aug; 195(4):1548-63. PubMed ID: 26157172
[TBL] [Abstract][Full Text] [Related]
20. Vanadate-induced inhibition of BCR-triggered apoptosis is coupled with tyrosine phosphorylation and induction of G2M growth arrest in Ramos-BL B cells.
Hristov KK; Knox KA; Mitev VI
Immunol Invest; 2007; 36(3):293-306. PubMed ID: 17558712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
